Seelos Therapeutics (SEEL) Prices $1.1M Share and Warrant Offering at $2.46/sh May 17, 2024 05:58AM
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules May 16, 2024 11:45PM
UPDATE: Roth Capital Upgrades Seelos Therapeutics (SEEL) to Buy Sep 27, 2021 08:41AM
Roth Capital Downgrades Seelos Therapeutics (SEEL) to Neutral, Following Clinical Business Update May 17, 2021 01:44PM
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering Sep 9, 2020 02:00PM


Sep 4, 2020 09:10AM Seelos Therapeutics (SEEL) Prices 8.865M Share Registered Direct Offering at $0.79/Sh
Sep 4, 2020 09:08AM Seelos Therapeutics Announces Pricing of $7.0 Million Registered Direct Offering
May 7, 2020 07:22AM Companies with NDRs 5/7
May 6, 2020 06:54AM Companies with NDRs 5/6
May 5, 2020 07:10AM Companies with NDRs 5/5
Feb 19, 2020 08:02AM Seelos Therapeutics to Participate in Two Upcoming Investor Conferences in March
Feb 19, 2020 08:02AM Seelos Therapeutics to Participate in Two Upcoming Investor Conferences in March
Sep 26, 2019 06:43AM Companies with NDRs 09/26
Aug 23, 2019 09:12AM Seelos Therapeutics (SEEL) Prices 4.475M Share Registered Direct Offering at $1.50/Sh
Aug 23, 2019 09:00AM Seelos Therapeutics Announces Pricing of $6.7 Million Registered Direct Offering
Aug 23, 2019 09:00AM Seelos Therapeutics Announces Pricing of $6.7 Million Registered Direct Offering
May 14, 2019 07:26AM Roth Capital Starts Seelos Therapeutics (SEEL) at Buy